543963-BOM

Shelter Pharma Ltd.

BSE: 543963

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

27.40+1.7 (+6.41%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

46.13

P/E (TTM)

5.11

P/B

0.60

P/S (TTM)

0.63

EV/EBITDA

3.60

CAPE (5Y)

5.94

ROE (TTM)

15.13

ROCE (TTM)

20.32

ROA (TTM)

13.62

Avg 3Y ROE

19.39

Earnings 3Y CAGR

4.67

Sales 3Y CAGR

26.47

Sales 5Y CAGR

26.61

Debt/Equity

0.01

Consensus TP

Strong Buy %

Promoter Holding

44.99

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Shelter Pharma Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 5.11 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -83.53%

What is P/E Ratio?

Median: 31.03

Value 5.11

-215.443203.67

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 44.36% for 12-month ended 31 Mar 2026 and the growth was 33.12 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 44.36

-82.35114662

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.01 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -17.58% for 12-month ended 31 Mar 2026 and the growth was 25.7 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Neutral

High ROE but declining trend

The company reported strong ROE of 15.13% for 12-month ended 31 Mar 2026 but ROE declined by -329 bps from 1 year ago

What is ROE (FY)?

High operating margin but declining trend

The company reported strong operating margin of 16.84% for 12-month ended 31 Mar 2026 but operating margin declined by -250 bps from 1 year ago

What is Operating profit margin?

Moderate dividend yield

The company has a moderate dividend yield of 1.28%

What is Dividend yield?

Financial Snapshot

See detailed analysis

Multi-year trends for Shelter Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Shelter Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Shelter Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2013	Sep 2014	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Total Promoter	11.89	11.89	100.00	100.00	100.00	100.00	56.89	56.89	54.97	52.32	52.32	52.32	44.99
Indian Promoter	11.89	11.89	100.00	100.00	100.00	100.00	56.89	56.89	54.97	52.32	52.32	52.32	44.99
Foreign Promoter	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	88.11	88.11	0.00	0.00	0.00	0.00	43.11	43.11	45.03	47.68	47.68	47.68	55.01
Bodies Corporate	0.00	0.00	0.00	0.00	0.00	0.00	10.62	10.91	1.15	1.10	1.25	1.28	1.03
Others (incl. Retail) No. of shareholders	88.11 0	88.11 7	0.00 0	0.00 0	0.00 0	0.00 0	32.49 822	32.20 851	43.88 1,094	46.58 1,127	46.43 1,085	46.40 1,069	53.98 1,033

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Shelter Pharma Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Krunal Vinodbhai Parmar	21 Jan 2026	buy	₹ 37.27	1.08 lac	-
Parvezbanu Mohamed Rafiq Idariya	21 Jan 2026	sell	₹ 37.49	1.32 lac	-
Aadit Shriniwas Akula	20 Jan 2026	buy	₹ 34.74	72.00 k	-
Parvezbanu Mohamed Rafiq Idariya	20 Jan 2026	sell	₹ 35.00	99.00 k	-
Parvezbanu Mohamed Rafiq Idariya	19 Jan 2026	sell	₹ 33.50	99.00 k	-

Corporate Actions

History of Shelter Pharma Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.35/share
Record date: 23rd Sep 2025Ex-date: 23rd Sep 2025
Announced on: 27th Aug 2025
Dividend₹ 0.33/share
Record date: 23rd Sep 2024Ex-date: 23rd Sep 2024
Announced on: 7th Sep 2024

Company Profile

Overview of Shelter Pharma Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Shelter Pharma Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing herbal products with a presence in human pharma as well as the veterinary space. It also has a product portfolio of OTC products as well as ethical pharma products. It has OTC and ethical presenc...

Key personnel

Mr. Mohammed Rafiq Gulamnabi Shaikh

Chief Financial Officer

Ms. Aarefa Kutub Kutub Kapasi

Compliance Officer, Company Secretary

Mr. Mustaqim Nisarahmed SabugarD

Managing Director, Executive Director

Mr. Shakil Nisarahmed SabugarD

Whole Time Director

Ms. Parvezbanu Mohamed Rafiq IdariyaD

Non-Executive Director

Mr. Riyajahmed Abdulrauf SabugarD

Non-Executive Independent Director

Mr. Mosinkhan Gafarkhan PathanD

Non-Executive Independent Director

Incorporated on

12 Oct 2007

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

23 Aug 2023

Free Float

66,42,792

Website

https://shelter.co.in/

Phone no.

+919898633551

Address

501, Sakar IV, Opp. Town Hall, Ashram Road,, AHMEDABAD, 380006, India

Frequently Asked Questions

What is the current share price of Shelter Pharma Ltd.?

The current share price of Shelter Pharma Ltd. is ₹ 27.40 as of 10 Jul 2026.

What is the market capitalisation of Shelter Pharma Ltd.?

The market capitalisation of Shelter Pharma Ltd. stands at ₹ 46.13 Cr.

What is the PE ratio of Shelter Pharma Ltd.?

The Price-to-Earnings (PE) ratio of Shelter Pharma Ltd. is 5.11 as of the latest trailing twelve months data.

What is the ROE and ROCE of Shelter Pharma Ltd.?

Shelter Pharma Ltd. has a Return on Equity (ROE) of 15.13% and a Return on Capital Employed (ROCE) of 20.32% as per the latest financial reports.

What is the 52-week high and low of Shelter Pharma Ltd.?

The 52-week high of Shelter Pharma Ltd. is - and the 52-week low is -.

What is the dividend yield of Shelter Pharma Ltd.?

The dividend yield of Shelter Pharma Ltd. is 1.28% based on the current market price.

What is the FII and DII holding in Shelter Pharma Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 53.98% of Shelter Pharma Ltd. shares.

What sector does Shelter Pharma Ltd. belong to?

Shelter Pharma Ltd. operates in the Healthcare sector.

What is the beta of Shelter Pharma Ltd.?

The beta of Shelter Pharma Ltd. is 1.01, indicating its price volatility relative to the broader market.

What is the RSI of Shelter Pharma Ltd.?

The 14-day Relative Strength Index (RSI) of Shelter Pharma Ltd. is 42.65, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Shelter Pharma Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Shelter Pharma Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile